Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
27%(3 trials)

Phase Distribution

Ph phase_2
2
18%
Ph phase_1
4
36%
Ph phase_4
3
27%
Ph phase_3
2
18%

Phase Distribution

4

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(11)

Detailed Status

Completed11

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (36.4%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 43 (27.3%)

Trials by Status

completed11100%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_4

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH

NCT04842019
completedphase_4

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

NCT04842032
completedphase_4

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

NCT05357573
completedphase_1

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

NCT01571596
completedphase_1

A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

NCT01340482
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT04842019Phase 4

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH

Completed
NCT04842032Phase 4

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

Completed
NCT05357573Phase 4

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO

Completed
NCT01571596Phase 1

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

Completed
NCT01340482Phase 1

A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

Completed
NCT00830674Phase 1

A Study of KRN23 in X-linked Hypophosphatemia

Completed
NCT02312687Phase 2

Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)

Completed
NCT03233126Phase 3

A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

Completed
NCT02722798Phase 2

A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome

Completed
NCT04308096Phase 3

A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

Completed
NCT02181764Phase 1

A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia

Completed

All 11 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
11